Mei C, Xu G, Zheng C, Xie Y, Li M, Shao Y, Yao R, Tao S, Jiang W, Guo J, Zheng Z, Wang W, Zhou X, Ma L, Ye L, Luo Y, Yang C, Yu W, Xie W, Jin J, Tong H. Recombinant human erythropoietin plus all-trans retinoic acid and testosterone undecanoate for the treatment of anemia in patients with lower-risk myelodysplastic syndromes: a multicenter, single-arm, prospective trial. haematol [Internet]. 2020Sep.10 [cited 2025Dec.5];. Available from: https://haematologica.org/article/view/12102